Mathias Haag
- Molecular Biology top 10%
- Epidemiology top 5%
- Hepatology top 2%
- Clinical Biochemistry top 1%
- Oncology
- Co-authors
- Thomas LangerMatthias SchwabTakashi TatsutaBritta BrüggerBenedikt WestermannFelix WielandStephan UrbanChristoph Potting
- Topics
- Metabolomics and Mass Spectrometry Studies (7 papers)Hepatitis B Virus Studies (7 papers)Mitochondrial Function and Pathology (6 papers)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Mathias Haag
34 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 96
- Molecular Biology 1.1k
- Epidemiology 744
- Hepatology 510
- Clinical Biochemistry 311
- Oncology 181
Countries citing papers authored by Mathias Haag
This map shows the geographic impact of Mathias Haag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathias Haag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathias Haag more than expected).
Fields of papers citing papers by Mathias Haag
This network shows the impact of papers produced by Mathias Haag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathias Haag. The network helps show where Mathias Haag may publish in the future.
Co-authorship network of co-authors of Mathias Haag
This figure shows the co-authorship network connecting the top 25 collaborators of Mathias Haag. A scholar is included among the top collaborators of Mathias Haag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathias Haag. Mathias Haag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 5 | |
| 3 | 4 | |
| 4 | 1 | |
| 5 | 4 | |
| 6 | 9 | |
| 7 | 5 | |
| 8 | 26 | |
| 9 | 16 | |
| 10 | 28 | |
| 11 | 78 | |
| 12 | 166 | |
| 13 | 21 | |
| 14 | a proof-of-concept Phase 2a clinical trial with Hbv/hdv entry inhibitor Myrcludex B : lb-20 | 24 |
| 15 | 160 | |
| 16 | 166 | |
| 17 | 185 | |
| 18 | 0 | |
| 19 | 23 | |
| 20 | 110 |
About Mathias Haag
Mathias Haag is a scholar working on Hepatology, Cancer Research and Molecular Biology, having authored 37 papers that have together received 1.9k indexed citations. Recurring topics across this work include Metabolomics and Mass Spectrometry Studies (7 papers), Hepatitis B Virus Studies (7 papers) and Mitochondrial Function and Pathology (6 papers). The work is most often cited by research in Hepatology (510 citations), Clinical Biochemistry (311 citations) and Epidemiology (744 citations). Mathias Haag has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Thomas Langer, Matthias Schwab, Takashi Tatsuta, Britta Brügger, Benedikt Westermann, Felix Wieland, Stephan Urban, Christoph Potting, Christof Osman and Antje Blank. Their work appears in journals such as Science, The Journal of Cell Biology and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.